F
F. Gekeler
Researcher at Ludwig Maximilian University of Munich
Publications - 5
Citations - 1415
F. Gekeler is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Randomized controlled trial & Placebo. The author has an hindex of 5, co-authored 5 publications receiving 1366 citations.
Papers
More filters
Journal ArticleDOI
Genome-wide, large-scale production of mutant mice by ENU mutagenesis
M. Hrabe de Angelis,Heinrich Flaswinkel,Helmut Fuchs,Birgit Rathkolb,Dian Soewarto,S. Marschall,Stephan Heffner,Walter Pargent,K. Wuensch,M. Jung,André Reis,Thomas Richter,Francesca Alessandrini,Thilo Jakob,Edith Fuchs,Hubert Kolb,Elisabeth Kremmer,K. Schaeble,B. Rollinski,Adelbert A. Roscher,Christoph Peters,Thomas Meitinger,T. M. Strom,Thomas Steckler,Florian Holsboer,Thomas Klopstock,F. Gekeler,C. Schindewolf,Thomas S. Jung,Karen B. Avraham,Heidrun Behrendt,Johannes Ring,Andreas Zimmer,Klaus Schughart,Klaus Pfeffer,Eckhard Wolf,Rudi Balling +36 more
TL;DR: In screening over 14,000 mice for a large number of clinically relevant parameters, 182 mouse mutants are recovered and this mutagenesis screen leads to a significant increase in the number of mouse models available to the scientific community.
Journal ArticleDOI
Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy and Deafness (DIDMOAD) Caused by Mutations in a Novel Gene (Wolframin) Coding for a Predicted Transmembrane Protein
Tim M. Strom,Konstanze Hörtnagel,Sabine Hofmann,F. Gekeler,Curt Scharfe,Wolfgang Rabl,K.-D. Gerbitz,Thomas Meitinger +7 more
TL;DR: One of these genes codes for a predicted transmembrane protein which was expressed in various tissues, including brain and pancreas, and carried loss-of-function mutations in both alleles in Wolfram syndrome patients.
Journal ArticleDOI
Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial.
Andreas Bender,W. Koch,Matthias Elstner,Y. Schombacher,Julia Bender,M. Moeschl,F. Gekeler,Bertram Müller-Myhsok,T. Gasser,Klaus Tatsch,Thomas Klopstock +10 more
TL;DR: Creatine improved patient mood and led to a smaller dose increase of dopaminergic therapy but had no effect on overall Unified Parkinson's Disease Rating Scale scores or dopamine transporter SPECT.
Journal ArticleDOI
A placebo-controlled crossover trial of creatine in mitochondrial diseases.
Thomas Klopstock,V. Querner,F. Schmidt,F. Gekeler,Maggie C. Walter,M. Hartard,M. Hennig Dipl-Stat,T. Gasser,Dieter Pongratz,Andreas Straube,Marianne Dieterich,W. Müller–Felber +11 more
TL;DR: In this paper, the efficacy and safety of creatine monohydrate in mitochondrial diseases were evaluated in 16 patients with chronic progressive external ophthalmoplegia or mitochondrial myopathy, who were randomized in a crossover design to receive double-blind placebo or 20 g Cr/day for 4 weeks.
Journal ArticleDOI
Diffusion-weighted magnetic resonance imaging during the aura of pseudomigraine with temporary neurologic symptoms and lymphocytic pleocytosis.
TL;DR: In this paper, the authors performed diffusion-weighted magnetic resonance imaging during the aura of a patient with lymphocytic pleocytosis and found no reduction of water diffusion.